Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 14

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 14
---
 registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”), the Tranche B Investors surrendered their October 2024 Noteholder Warrants in exchange for the Exchange
Warrants to purchase an aggregate amount of 500,000 shares of Common Stock. The closing for the Exchange Warrants occurred on July 28, 2025 and the Exchange Warrants have an exercise price of $40.00 per share (subject to adjustment as described
in this prospectus).

Background of Issuance of the September 2025 Warrants

On September 30, 2025, we entered into Warrant Exercise Agreements with the September 2025 Warrant Holders. Pursuant to the Warrant
Exercise Agreement, the September 2025 Warrant Holders exercised in full their respective December 2024 RDO Common Warrants originally issued to the September 2025 Warrant Holders pursuant to the December 2024 RDO Purchase Agreement
for an aggregate of 179,236 shares of Common Stock and deferred, for a deferral fee of $7.72 per share being exercised, their right to receive an amortization payment scheduled to be paid by the Company on October 1, 2025 as set forth in
the amortization schedule included in Tranche B Note issued to, among others, each September 2025 Warrant Holder in exchange for the Company’s agreement to issue the September 2025 Warrants. The closing for the Warrant Exercise
Agreement occurred on September 30, 2025 and the September 2025 Warrants have an exercise price of $20.00 per share (subject to adjustment as described in this prospectus).

Background of Issuance of the November 2025 Warrants

On November 23, 2025, we entered into the Warrant Inducement Agreement with the Exercising Investor. Pursuant to the Warrant Inducement
Agreement, the Exercising Investor exercised (i) an April 2024 RDO Common Warrant issued to the Exercising Investor pursuant to the April 2024 RDO Purchase Agreement, which was exercisable for 428,572 shares and had an exercise price of
$38.50 per share and (ii) a December 2024 RDO Common Warrant issued to the Exercising Investor pursuant to the December 2024 RDO Purchase Agreement, which was exercisable for 475,